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Planar chiral palladacycle precatalysts for
asymmetric synthesis†
Ross A. Arthurs, David L. Hughes and Christopher J. Richards *
Chiral non-racemic palladacycles were employed as precatalysts for Pd(0) mediated asymmetric synthesis.
Addition of HPAr2/base to a ferrocenyloxazoline planar chiral palladacycle resulted in ligand synthesis and
palladium capture to give a bidentate Phosferrox/Pd(0) complex. A series of these complexes were gener-
ated in situ and applied successfully as catalysts for asymmetric allylic alkylation.
Introduction
Air-stable palladacycles containing a bidentate carbon-hetero-
atom ligated palladium(II) core have been employed extensively
in catalysis.1 Following the discovery that high turn-over
numbers may be achieved on application of the Herrmann
complex to the Heck reaction,2 this and other palladacycles
have also found application in a number of cross-coupling pro-
cesses including the Suzuki–Miyaura3 and Buchwald–Hartwig
amination reactions.4 In addition, related chiral non-racemic
palladacycles have been applied successfully to the catalysis of
asymmetric reactions.5 Examples include the allylic imidate
rearrangement,6 hydrophosphination,7 imine arylation,8 the
aza-Morita–Baylis–Hillman reaction9 and Michael type reac-
tions.10 Palladium(II) mediated activation of the substrate and
retention of the palladacycle C–Pd bond in the chiral catalyst
is either demonstrated11 or invoked.7–10 A recent report on pal-
ladacycle catalysed asymmetric Suzuki cross-coupling was
explained by the operation of a Pd(II)/Pd(IV) catalytic cycle.12 In
contrast, the use of chiral non-racemic palladacycles as preca-
talysts for asymmetric reactions proceeding via a Pd(0)/Pd(II)
catalytic cycle does not appear to have been demonstrated.13
In this paper we describe the use of chiral non-racemic pal-
ladacycles as precatalysts for the formation of Pd(0)/chiral
ligand coordinated complexes, followed by the application of
these as catalysts in asymmetric synthesis. This first report on
simultaneous bidentate ligand synthesis/palladium(0) capture
provides a new and versatile approach to the generation of Pd/
chiral ligand complexes, with potential applications across a
range of palladium catalysed asymmetric transformations.14
Results and discussion
Palladacycles are known to undergo ligand phosphination on
reaction with MPPh2 (M = Li, K), where initial phosphide
coordination to palladium followed by reductive elimination
results in C–P bond formation.15,16 In this way a number of N–
P, S–P and P–P bidentate ligands have been synthesised from
the corresponding S, N or P precursor palladacycles. Many of
these product ligands are chiral, including planar chiral
examples displaying stereospecific replacement of the C–Pd
bond by a new C–P bond.15a,b Formation of these ligands also
results in the generation of Pd(0), but as far as we are aware,
isolation of a resulting ligated Pd(0) complex in this way has
not been reported, let alone used subsequently in catalysis.
To address this challenge we chose to start with ferroceny-
loxazoline (S)-1 17 as this may be transformed readily into
planar chiral palladacycles (S,Sp)-2a/b (Scheme 1).
18
Furthermore, the Phosferrox ligand (S,Sp)-3
19 is also derived
from (S)-1, this bidentate ligand having been applied success-
fully in several palladium catalysed asymmetric reactions.20 It
was anticipated that this would aid the identification and com-
parative application of a corresponding palladacycle derived
Pd(0) complex of (S,Sp)-3.
We reasoned that identification of in situ formed P–N
ligated Pd(0) would be aided by addition of a second ligand to
Scheme 1 Palladacycles and a chiral bidentate ligand derived from (S)-
1.
†Electronic supplementary information (ESI) available: Additional experimental
detail, copies of the 1H, 13C and 31P NMR spectra, HPLC traces and details of the
X-ray crystal structure determination. CCDC 1983850. For ESI and crystallo-
graphic data in CIF or other electronic format see DOI: 10.1039/d0ob01331e
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give a readily characterised complex. As maleic anhydride (MA)
is known to result in stable low valent complexes of palla-
dium,21 we first used this electron deficient alkene with (S,Sp)-
3 and Pd2(dba)3 for the synthesis of (S,Sp)-4 (Scheme 2). This
air-stable Pd(0) complex was purified readily by column
chromatography. Its 31P NMR spectrum22 contained character-
istic major and minor signals at 14.39 and 15.81 ppm respect-
ively due to the two possible (exo/endo) orientations of the
cyclic unsaturated ligand.
Phosphine complexes of palladacycles (S,Sp)-2a/b were first
investigated using triphenylphosphine. On combination in
CH2Cl2 at room temperature monomeric adducts 5a/b were
formed cleanly (Scheme 2). The phosphine is assigned a trans
to nitrogen orientation in the resulting complexes in accord
with the geometry of related monomeric phosphine co-
ordinated palladacycles.15b,23 The 31P NMR signals22 observed
for 5a (36.5 ppm) and 5b (37.5 ppm), compared to PPh3
(−5.4 ppm), were used to aid the assignment of the corres-
ponding adducts obtained from HPPh2 (−40.1 ppm). Addition
of this secondary phosphine to chloride ligated 2b gave stable
and isolable adduct 6b (8.4 ppm). In contrast, addition to
acetate ligated 2a resulted in immediate darkening to brown/
black of the initially orange solution, and after stirring for
1 hour, no phosphine adduct was obtained.
To investigate the possibility that this colour change was
indicative of reductive elimination from an initially formed
phosphine adduct, the experiment was repeated in CD2Cl2 and
followed by 31P NMR spectroscopy. Following addition of
HPPh2 to 2a at room temperature, a major signal observed in
the 31P NMR spectrum obtained after ca. 10 minutes (7.5 ppm)
is indicative of adduct 6a (Fig. 1a). Significantly, following the
addition of MA, subsequent NMR analysis revealed the dis-
appearance of this complex and the formation of (S,Sp)-4
(Fig. 1b).
Two other major signals at 27.3 and 55.2 ppm were
observed in the 31P NMR spectra obtained before and after the
addition of MA. The first corresponds to (S,Sp)-7, a phosferrox
derived phosphine oxide for which the identity was confirmed
by independent synthesis. The second is assigned to a Pd(II)/
PPh2 complex (vide infra). Formation of 4 was not observed
when MA was added to palladacycle 2a before the addition of
PHPh2 due to fast competitive Michael addition.
24 The for-
mation of 4 and 7, as a single diastereoisomer in both cases,
confirms that replacement of palladium by phosphorus pro-
ceeds with no erosion of stereochemical integrity.25
In contrast to 6a, the corresponding experiment with chlor-
ide complex 6b (formed in situ from (S,Sp)-2b and HPPh2)
required the addition of a base to promote reductive elimin-
ation and formation of the MA adduct 4. Nitrogen bases were
employed initially, with triethylamine resulting in the highest
conversion (14%) as determined by 31P NMR spectroscopy.26
With N,O-bis(trimethylsilyl)acetamide (BSA) the conversion
was improved (23%), and the best result (29%) was obtained
with sodium dimethyl malonate. Following addition of this
base 31P NMR spectroscopy revealed two major signals at
−18.1 and 23.8 ppm (Fig. 1c). The former corresponds to
Phosferrox ligand 3, and on addition of MA this signal dis-
appeared and was replaced predominantly by a corresponding
amount of 4 (Fig. 1d). Following isolation of the other complex
by column chromatography it was identified by X-ray crystallo-
graphy as Pd(II)/PPh2 dimer 8b (Scheme 3 and Fig. 2).
27
Addition of silver acetate to 8b gave 8a (31P NMR =
−55.6 ppm), revealing that this corresponding acetate-bridged
dimer is formed from the addition of HPPh2 to 2a (Fig. 1a and
b). Addition of maleic anhydride to a solution of 8b in CD2Cl2
did not result in the formation of 4. Dimerisation to give 8a/b
is an alternative and apparently irreversible pathway to reduc-
tive elimination and formation of ligand 3. It is of note that Pd
(0) does not complex with 3 to a significant extent until maleic
anhydride is added, an outcome consistent with initial and
reversible formation of palladium nanoparticles.28 No oxi-
dation to phosphine oxide (S,Sp)-7 was observed, in contrast to
Scheme 2 Synthesis of Pd(0) complex (S,Sp)-4 by ligand exchange and
ligand synthesis/palladium capture.
Fig. 1 31P NMR spectra (CD2Cl2): (a) following the addition of HPPh2 (2
eq.) to 2a, (b) ca. 10 minutes after the addition of MA (2 eq.), (c) following
the addition of NaCH(CO2Me)2 (10 eq.) to 6b, (d) ca. 1 h after the
addition of MA (4 eq.).
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the appreciable formation of this compound from acetate-
bridged palladacycle 2a, revealing a significant advantage of
starting with chloride-bridged palladacycle 2b.29
The successful formation of (S,Sp)-4 from palladacycle pre-
cursors prompted us to investigate the use of these as precata-
lysts in asymmetric synthesis. The allylic alkylation of trans-
1,3-diphenylallyl acetate 9 was chosen as an exemplar reaction
due to its experimental simplicity and the potential to employ
the basic reaction conditions for in situ ligand/Pd(0) gene-
ration (Table 1). Furthermore, ligand (S,Sp)-3 is known to
promote high enantioselectivity in this reaction, and in our
hands repetition of conditions reported previously20a using
BSA as base (3 eq.) gave (S)-10 in 95% ee (conditions A,
Table 1, entry 1). Replacing [Pd(C3H5)Cl]2 with preformed Pd
(0) complex (S,Sp)-4 resulted in some loss of enantioselectivity,
and a very significant reduction in activity due to inhibition by
maleic anhydride (entry 2). This precluded the use of this
π-acidic ligand in any subsequent runs. Instead, a catalytic
asymmetric allylic alkylation was attempted directly following
the addition of HPPh2 to 2a, and after stirring for 10 minutes,
to resulting in situ generated 6a was added sequentially rac-9,
dimethyl malonate, BSA and KOAc (entry 3). Although slow, we
noted with interest the formation of product 10, subsequently
isolated as the S enantiomer in 85% ee. Use in the same way of
chloride 2b resulted in a similar outcome (entry 4), and on rep-
etition in the absence of KOAc the product ee increased to
94% (entry 5). No product was formed in the absence of added
PHPh2 (entry 6). These initial results are consistent with the
in situ formation of (S,Sp)-3 ligated Pd(0) as the sole catalyti-
cally active species, albeit in low concentration. Replacement
of CH2Cl2 as solvent with THF or toluene resulted in no
product formation.
As sodium dimethyl malonate gave the highest and cleanest
conversion to (S,Sp)-4, this was employed next as both a base
and a nucleophile, and the process referenced initially by use
of (S,Sp)-3/[Pd(C3H5)Cl]2 (3 fold excess, conditions B). The
lower product ee, compared to that obtained from the use as
base of BSA (95% – entry 1 vs. 88% – entry 7) is consistent with
the superiority of the former conditions noted previously.30
Significantly, addition of a three-fold excess of sodium
dimethyl malonate to rac-9 and 2 mol% of in situ generated 6b
resulted in complete conversion within 2.5 h to allylic alkyl-
ation product (S)-10 formed in 77% ee (entry 8). Modifying
these conditions further (conditions C) to the use sodium
dimethyl malonate (10 mol%) as the base for in situ catalyst
formation, and then the addition of BSA/dimethyl malonate (3
equivalents of each) further decreased the reaction time to
1 hour and increased the ee of (S)-10 to 86% (entry 9). The use
of conditions C provided an in situ generated catalyst with
Fig. 2 A representation of the X-ray structure of 8b (hydrogen atoms
omitted for clarity). Principal bond lengths [Å] include: Pd(1)–Cl(1) =
2.4308(6), Pd(2)–Cl(1) = 2.4366(6), Pd(1)–P(1) = 2.2447(6), Pd(2)–P(1) =
2.2457(6). Principal bond angles [deg] include: Pd(1)–Cl(1)–Pd(2) =
86.641(18), Pd(1)–P(1)–Pd(2) = 96.09(2). Thermal ellipsoids are drawn at
the 50% probability level. Flack parameter = −0.002(5).
Table 1 Comparative catalysis of asymmetric allylic alkylation with pre-
formed and palladacycle generated Phosferrox/Pd(0) complexesa







1 (S,Sp)-3 (2.5) + [Pd(C3H5)Cl]2
(1)
A <1 100 95b
2 (S,Sp)-4 (1) A 96 6 86
3 (S,Sp)-2a (1) + HPPh2 (2) A 96 51 85
4 (S,Sp)-2b (1) + HPPh2 (2) A 96 77 85
5 (S,Sp)-2b (1) + HPPh2 (2) A
c,d 96 20 94
6 (S,Sp)-2a (1) or (S,Sp)-2b (1) A 96 0 na
7 (S,Sp)-3 (2.5) + [Pd(C3H5)Cl]2
(1)
B 3.5 100 88
8 (S,Sp)-2b (1) + HPPh2 (2) B 2.5 100 77
9 (S,Sp)-2b (1) + HPPh2 (2) C 1 99 86
10 8b (1) A 24 0 na
11 (S,Sp)-2b (1) + 11a (2) C 24 18 85
12 (S,Sp)-2b (1) + 11b (2) C 24
e 100 84
13 (S,Sp)-2b (1) + 11c (2) C 24
e 100 83
a 1 mmol rac-9 (0.6 M) unless otherwise stated. b Lit. value 90% ee.20a
c 0.33 mmol scale. dNo KOAc. e Reaction essentially complete within
1 h (tlc).
Scheme 3 The generation of (S,Sp)-4. by ligand synthesis/palladium
capture from palladacycle 2b.
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comparable activity and selectivity to that obtained using a
preformed ligand, and consistent with this outcome is the
absence of any catalysis with Pd(II) complex 8b (entry 10).
Finally, this led us to explore the use of asymmetric allylic
alkylation to test the viability of using electronically contrast-
ing diarylphosphines in the ligand synthesis/Pd(0) capture pro-
tocol (Scheme 4). For this reaction previous work with related
PHOX ligands containing PAr2 units with various para substi-
tuents revealed little difference in enantioselectivity compared
to the parent PPh2 containing ligand,
31 albeit with faster con-
version with electron-withdrawing substituents.31a
Accordingly, secondary phosphines 11a–c were added separ-
ately to palladacycle (S,Sp)-2b followed by sodium dimethyl
malonate, and to the resulting solutions were added rac-9 (50
equivalents w.r.t. Pd) and dimethyl malonate/BSA (i.e. con-
ditions C). Use of electron-deficient phosphine 11a resulted in
a similar level of product enantioselectivity albeit in reduced
yield (Table 1, entry 11). Further examination by 31P NMR spec-
troscopy (CD2Cl2) of the addition of 11a (−40.8 ppm) to 2b
confirmed the formation of the phosphine coordinated adduct
(10.9 ppm), but little Pd0 complex was observed following the
addition of sodium dimethyl malonate and MA. In this
instance catalyst formation appears to be limited by the ineffi-
ciency of reductive elimination.32 In contrast, the catalysts
derived from phosphines 11b (entry 12) and 11c (entry 13)
gave essentially complete conversion after 1 h and ee values
very similar to that obtained from diphenylphosphine.
Conclusion
We have established that ferrocenyloxazoline-based planar
chiral palladacycles 2a/b, on combination with diphenyl-
phosphine (and for 2b a base), are viable precatalysts for
in situ catalyst generation using a new ligand synthesis/palla-
dium(0) capture approach. This was demonstrated by for-
mation of a stable Phosferrox/maleic anhydride coordinated
Pd(0) complex (S,Sp)-4a, and by application of Phosferrox/Pd(0)
as a catalyst for asymmetric allylic alkylation in the absence of
maleic anhydride. The other palladium(II) complex formed in
this process is not a competitive catalyst or catalyst precursor.
Product configuration and enantioselectivity using a pallada-
cycle derived catalyst are similar to that obtained using a pre-
formed Phosferrox ligand and a source of Pd(0). In addition to
being a precursor to an active and selective catalyst generated
in one step, palladacycle 2b may also be used for multiple cata-
lyst generation with other diarylphosphines. It is anticipated
that this approach will aid significantly the generation and
identification of palladium based catalysts for application in
other areas of asymmetric synthesis.
Experimental
General information
Tetrahydrofuran was distilled over sodium and benzophenone
ketyl and dichloromethane distilled over calcium hydride. All
reactions were carried out under an inert atmosphere of either
nitrogen or argon. Silica gel (60 Å pore size, 40–63 µm techni-
cal grade) was used for chromatography. All starting materials
not commercially available are specifically referenced.
Synthesis of (S,Sp)-4
(S,Sp)-3
19 (0.087 g, 0.18 mmol), tris(dibenzylideneacetone)-
dipalladium(0) (0.076 g, 0.08 mmol) and maleic anhydride
(0.024 g, 0.24 mmol) were added to a flame dried Schlenk tube
and dissolved in toluene (15 mL). The resulting deep purple
solution was stirred vigorously overnight resulting in the for-
mation of a dark suspension. The reaction was filtered
through Celite™ using toluene as the eluent and the solvent
removed in vacuo. Purification by column chromatography
(SiO2, 40% EtOAc/hexane) yielded an orange solid (0.07 g,
61%); mp decomposed ∼200 °C (under argon); HRMS (AS) [M
+ H]+ anal. calcd for C32H31FeNO4PPd 686.0389, found
686.0389; [α]20:5°CD = −538 (c = 0.46, CHCl3); νmax (film)/cm
−1
3056, 3016, 2960, 2923, 2873, 1790, 1723, 1626; 1H NMR
(500 MHz, CDCl3) major isomer (ratio of isomers = 1.6 : 1) δ
7.80 (2H, ddd, J = 11.6, 7.8, 1.5 Hz), 7.56–7.46 (3H, m),
7.33–7.27 (3H, m), 7.08 (2H, ddd, J = 11.0, 6.6, 3.2 Hz), 5.04
(1H, brs), 4.70 (1H, t, J = 2.6 Hz), 4.41–4.38 (1H, m), 4.35 (1H,
t, J = 3.7 Hz), 4.33–4.21 (3H, m), 4.07 (1H, dd, J = 10.5, 3.8 Hz),
3.96 (5H, s), 2.80 (1H, dtd, J = 13.8, 6.9, 3.3 Hz), 1.07 (3H, d, J =
7.1 Hz), 0.99 (3H, d, J = 6.9 Hz); minor isomer 7.76–7.68 (2H,
m), 7.56–7.46 (3H, m), 7.33–7.27 (3H, m), 7.21–7.14 (2H, m),
5.04 (1H, brs), 4.72 (1H, t, J = 2.6 Hz), 4.50–4.46 (1H, m),
4.33–4.21 (3H, m), 3.86 (5H, s), 3.87–3.79 (2H, m), 2.67 (1H,
dtd, J = 13.7, 6.9, 3.4), 1.04 (3H, d, J = 7.0 Hz), 0.95 (3H, d, J =
6.8 Hz); 13C NMR (125 MHz, CDCl3) major isomer δ 172.6 (d, J
= 2.0 Hz), 171.5 (d, J = 5.2 Hz), 169.1, 135.5 (d, J = 36.7 Hz),
134.9 (d, J = 16.7 Hz), 134.7 (d, J = 40.1 Hz), 131.6 (d, J = 13.3
Hz), 131.2 (d, J = 2.0 Hz), 129.4 (d, J = 1.6 Hz), 128.6 (d, J = 10.8
Hz), 128.5 (d, J = 9.7 Hz), 75.5 (d, J = 2.6 Hz), 74.0 (d, J = 2.3
Hz), 73.5 (d, J = 46.2 Hz), 73.4 (d, J = 1.5 Hz), 73.1, 71.8 (d, J =
0.5 Hz), 71.4, 67.7, 47.4 (d, J = 31.7 Hz), 46.4 (d, J = 1.8 Hz),
29.2, 19.2, 14.7; minor isomer 172.9 (d, J = 1.5 Hz), 171.2 (d, J =
5.0 Hz), 169.1, 137.3 (d, J = 37.8 Hz), 135.1 (d, J = 16.6 Hz),
133.7 (d, J = 40.2 Hz), 131.4 (d, J = 13.1 Hz), 131.4 (d, J = 2.1
Hz), 129.1 (d, J = 1.5 Hz), 128.8 (d, J = 11.2 Hz), 128.5 (d, J = 9.7
Scheme 4 Phosphine variation for in situ ligand synthesis/Pd(0)
capture from palladacycle (S,Sp)-b2.
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Hz), 75.9 (d, J = 2.7 Hz), 75.1 (d, J = 1.8 Hz), 74.0 (d, J = 33.0
Hz), 74.0 (d, J = 2.1 Hz), 73.4 (d, J = 1.3 Hz), 73.1, 71.6, 67.7,
47.8 (d, J = 1.7 Hz), 46.7 (d, J = 32.7 Hz), 29.2, 19.2, 14.9; 31P
NMR (202 MHz, CDCl3) major isomer δ 14.39; minor isomer
15.81.
General procedure for the synthesis of 5a, 5b and 6b
(S,Sp)-2a
18a,b or (S,Sp)-2b
18b (0.029 mmol) and either triphenyl-
phosphine or diphenylphosphine (0.057 mmol) were added to
a flame dried Schlenk tube and dissolved in dichloromethane
(1 mL) and stirred at room temperature for 1 hour. The solvent
was removed in vacuo yielding the product.
5a. Obtained as a deep orange solid (0.034 g, 83%): mp
136–137 °C (under argon), MS (EI) [M]+ anal. calcd for
C36H36FeNO3PPd 723.1, found 723.1; [α]23:5°CD = −572 (c = 0.55,
MeCN); νmax (film)/cm
−1 3052, 2961, 2925, 2871, 1615, 1582,
1499; 1H NMR (500 MHz, MeCN-d3) δ 7.78–7.72, (6H, m),
7.52–7.48 (3H, m), 7.46–7.41 (6H, m), 4.63 (1H, t, J = 9.5 Hz),
4.59–4.55 (1H, m), 4.45 (1H, d, J = 1.9 Hz), 4.07 (1H, ddd, J
10.0, 7.5, 4.2 Hz), 4.02 (1H, t, J = 2.2 Hz), 3.90 (5H, s), 3.30 (1H,
d, J = 2.2 Hz), 2.34–2.26 (1H, m), 1.25 (3H, s), 1.03 (3H, d, J =
6.9 Hz), 0.88 (3H, d, J = 7.2 Hz); 13C NMR (125 MHz, MeCN-d3)
δ 179.8, 176.3, 135.7 (d, J = 12.0 Hz), 132.1 (d, J = 50.3 Hz),
131.5 (d, J = 2.4 Hz), 129.1 (d, J = 10.7 Hz), 90.2 (d, J = 8.6 Hz),
77.3 (d, J = 9.0 Hz), 73.8 (d, J = 1.3 Hz), 73.1 (d, J = 3.0 Hz),
70.9, 69.7 (d, J = 2.6 Hz), 68.3 (d, J = 3.3 Hz), 65.6, 29.3, 23.9,
19.3, 15.7; 31P NMR (202 MHz, MeCN-d3) δ 36.48.
5b. Purified by column chromatography (SiO2, 20% EtOAc/
hexane) to give the product as a deep orange solid (0.038 g,
95%): mp decomposed ∼230 °C (under argon); HRMS (AS)
[M-Cl]+ anal. calcd for C34H33FeNOPPd 664.0699, found
664.0711; [α]22:8°CD = −825 (c = 0.26, MeCN); νmax (film)/cm
−1
3077, 3052, 2958, 2925, 2867, 1618, 1503; 1H NMR (500 MHz,
MeCN-d3) δ 7.78–7.72 (6H, m), 7.53–7.49 (3H, m), 7.48–7.43
(6H, m), 4.67–4.57 (2H, m), 4.47 (1H, d, J = 1.9 Hz), 4.18 (1H,
ddd, J = 10.2, 6.3, 4.2 Hz), 4.02 (1H, t, J = 2.1 Hz), 3.97 (5H, s),
3.04 (1H, brs), 2.87 (1H, brs), 1.06 (3H, d, J = 6.9 Hz), 0.92 (3H,
d, J = 7.2 Hz); 13C NMR (125 MHz, MeCN-d3) δ 179.9, 135.6 (d,
J = 11.7 Hz), 132.9 (d, J = 51.3 Hz), 131.6, 129.1 (d, J = 10.8 Hz),
94.6, 75.9 (d, J = 8.7 Hz), 74.2, 73.3, 70.9, 69.4, 68.0 (d, J = 3.1
Hz), 65.6, 29.4, 19.2, 15.5; 31P NMR (202 MHz, MeCN-d3) δ
37.49.
6b. Obtained as a deep orange solid (0.025 g, 73%): mp
110–112 °C (under argon), MS (EI) [M]+ anal. calcd for
C28H29ClFeNOPPd 623.0, found 623.0; [α]22:8°CD = −882 (c =
0.20, MeCN); νmax (film)/cm
−1 3077, 3055, 2961, 2929, 2871,
1615, 1503; 1H NMR (500 MHz, MeCN-d3) δ 8.05 (2H, dd, J =
12.0, 7.4 Hz), 7.88 (2H, dd, J = 12.7, 7.3 Hz), 7.58–7.49 (4H, m),
7.47 (2H, td, J = 7.3, 2.0 Hz), 6.56 (1H, d, J = 388.9 Hz), 4.64
(1H, dd, J = 9.0, 6.2 Hz), 4.57 (1H, t, J = 9.7 Hz), 4.54 (1H, d, J =
2.2 Hz), 4.45 (1H, brs), 4.37 (1H, t, J = 2.4 Hz), 4.17–4.12 (1H,
m), 4.07 (5H, s), 2.90 (1H, brs), 1.04 (3H, d, J = 5.9 Hz), 0.90
(3H, d, J = 7.0 Hz); 13C NMR (125 MHz, MeCN-d3) δ 179.9,
135.2 (d, J = 11.1 Hz), 134.8 (d, J = 11.4 Hz), 132.2 (d, J = 2.6
Hz), 132.0 (d, J = 2.6 Hz), 129.9 (d, J = 10.8 Hz), 129.7 (d, J =
11.0 Hz), 129.5 (d, J = 51.2 Hz), 129.5 (d, J = 52.8 Hz), 91.6 (d, J
= 8.0 Hz), 74.8 (d, J = 1.0 Hz), 73.8 (d, J = 15.7 Hz), 73.2 (d, J =
3.2 Hz), 70.7, 70.2 (d, J = 4.5 Hz), 68.0 (d, J = 3.4 Hz), 66.8, 29.2,
19.1, 15.1; 31P NMR (202 MHz, MeCN-d3) δ 8.44.
Synthesis of (S,Sp)-7
(S)-1 17 (0.059 g, 0.2 mmol) was added to a flame dried Schlenk
tube under an atmosphere of argon and dissolved in dry THF
(5 mL). The resulting orange solution was cooled to −78 °C
and stirred for 5 min after which n-butyl lithium (2.5 M in
hexanes) (0.11 mL, 0.28 mmol) was added slowly. After stirring
for 2 hours the mixture was warmed to 0 °C and chlorodiphe-
nylphosphine oxide (0.076 mL, 0.4 mmol) was added and the
reaction was allowed to warm to room temperature. After an
additional 15 min, the reaction was diluted with diethyl ether
and then quenched with saturated sodium hydrogen carbonate
solution. The organics were separated with H2O, washed with
brine, dried over MgSO4 and the solvent removed in vacuo
giving a crude product containing a 2 : 1 mixture of diastereo-
isomers. The diastereoisomers were separated by column
chromatography (SiO2, 2% MeOH/Et2O) yielding the desired
product as a yellow brown solid (0.0255 g, 26%): mp
197–198 °C; HRMS (ES) [M + H]+ anal. calcd for C28H29FeNO2P
498.1280, found 498.1263; [α]19:4°CD = +114 (c = 0.2, CHCl3); νmax
(film)/cm−1 3080, 3062, 2963, 2930, 2871, 1648, 1120; 1H NMR
(500 MHz, CDCl3) δ 7.76–7.71 (2H, m), 7.69–7.64 (2H, m),
7.50–7.46 (1H, m), 7.45–7.36 (5H, m), 5.06 (1H, dt, J = 2.6, 1.4
Hz), 4.49 (5H, s), 4.45 (1H, dd, J = 4.4, 2.4 Hz), 4.22–4.18 (1H,
m), 3.93 (1H, dd, J = 3.9, 2.5 Hz), 3.72 (1H, td, J = 9.3, 6.3 Hz),
3.13 (1H, t, J = 8.8 Hz), 1.53–1.47 (1H, m), 0.81 (3H, d, J = 6.8
Hz), 0.61 (3H, d, J = 6.8 Hz); 13C NMR (125 MHz, CDCl3) δ
164.6, 134.86 (d, J = 107 Hz), 134.8 (d, J = 110.4 Hz), 131.6 (d, J
= 9.3 Hz), 131.4 (d, J = 9.7 Hz), 131.3 (d, J = 2.6 Hz), 131.0 (d, J
= 2.9 Hz), 128.2 (d, J = 4.3 Hz), 128.1 (d, J = 4.8 Hz), 78.5 (d, J =
14.6 Hz), 75.7 (d, J = 109.9 Hz), 74.5 (d, J = 9.1 Hz), 73.5 (d, J =
8.2 Hz), 72.4, 71.5 (d, J = 10.9 Hz), 71.4, 70.1, 32.3, 19.2, 18.0;
31P NMR (202 MHz, CDCl3) δ 26.40.
Synthesis of (S,S,Sp,Sp)-8b
To a flame dried Schlenk tube (tube-1) was added sodium tert-
butoxide solution (2 M in THF) (0.05 mL, 0.10 mmol) followed
by a solution of dimethyl malonate (22.6 µl, 0.20 mmol) in
THF (1 mL) at 0 °C. After stirring for 30 min the solvent was
removed under high vacuum to give a beige residue. In a sep-
arate flame dried Schlenk tube (tube-2), (S,Sp)-6b (0.0125 g,
0.020 mmol) was dissolved in CH2Cl2 (1.7 mL) and then the
contents of Schlenk tube (2) were transferred to Schlenk tube
(1) and stirred at room temperature for 10 min. The solvent
was then removed in vacuo and the residue purified by column
chromatography (SiO2, 10% EtOAc/hexane) to give an orange
solid (0.007 g, 70%): mp > 230 °C (under argon); HRMS (AS)
[M − Cl]+ anal. calcd for C44H46Fe2N2O2PPd2 991.0103, found
991.0093; [α]20:1°CD = −2000 (c = 0.23, CHCl3); νmax (film)/cm
−1
3096, 2958, 2923, 2967, 1617, 1495; 1H NMR (500 MHz, CDCl3)
δ 8.12–8.05 (4H, m), 7.38–7.34 (6H, m), 4.49–4.47 (4H, m), 4.36
(2H, d, J = 1.8 Hz), 4.08 (2H, td, J = 8.0, 4.6 Hz), 4.04 (10H, s),
4.02 (2H, t, J = 2.3 Hz), 3.22 (2H, d, J = 1.6 Hz), 2.51–2.43 (2H,
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m), 1.06 (6H, d, J = 6.8 Hz), 0.97 (6H, d, J = 7.0 Hz); 13C NMR
(125 MHz, CDCl3) δ 177.9, 137.2 (d, J = 32.8 Hz), 135.4 (d, J =
12.7 Hz), 128.8, 127.8 (d, J = 10.5 Hz), 91.4 (d, J = 2.9 Hz), 75.1
(d, J = 8.6 Hz), 73.3 (d, J = 1.6 Hz), 72.2, 70.0, 69.0, 66.9, 64.5,
29.3, 19.6, 16.0; 31P NMR (202 MHz, CDCl3) δ 23.40.
Synthesis of (S,S,Sp,Sp)-8a
Addition of excess AgOAc to an NMR tube containing (S,S,Sp,
Sp)-8b showed the formation of acetate bridged palladacycle (S,
S,Sp,Sp)-8a; νmax (film)/cm
−1 3096, 2958, 2919, 2849, 1621,
1556, 1495; 1H NMR (500 MHz, CDCl3) δ 8.12–7.97 (4H, m),
7.33–7.27 (6H, m), 4.51–4.46 (4H, m), 4.34 (2H, brs), 4.09–4.03
(2H, m), 4.00 (10H, s), 3.97 (2H, brs), 3.00 (2H, brs), 2.70–2.60
(2H, m), 2.01 (3H, brs), 1.04 (6H, d, J = 6.8 Hz), 0.95 (6H, d, J =
7.1 Hz); 31P NMR (202 MHz, CDCl3) δ 55.63.
Phosphine insertion studies
Using a glove box, 0.01 mmol of either (S,Sp)-2a or (S,Sp)-2b
was dissolved in CD2Cl2 (0.7 mL) in an NMR tube fitted with a
J. Young valve under an inert atmosphere. After addition of the
reagents approximately 10 minutes elapsed before the first
NMR spectrum was recorded.
In situ catalyst preparation and asymmetric allylic alkylation
(conditions C)
To a flame dried Schlenk tube (tube-1) was added sodium
tert-butoxide solution (2 M in THF) (0.05 mL, 0.10 mmol) fol-
lowed by a solution of dimethyl malonate (22.6 µl,
0.20 mmol) in THF (1 mL) at 0 °C. After stirring for 30 min
the solvent was removed under high vacuum to give a beige
residue. In a separate flame dried Schlenk tube (tube-2), (S,
Sp)-2b (0.0088 g, 0.010 mmol) was dissolved in CH2Cl2
(1.7 mL) and phosphine (0.020 mmol) was added and stirred
for 10 min. 1,3-Diphenylallyl acetate (0.252 g, 1.0 mmol) was
dissolved in CH2Cl2 (1.7 mL) and then added to Schlenk tube
(2) followed by dimethyl malonate (0.34 mL, 3.0 mmol). The
contents of Schlenk tube (2) were transferred to Schlenk tube
(1) and stirred for 5 min after which N,O-bis(trimethylsilyl)
acetamide (0.74 mL, 3.0 mmol) was added and the reaction
allowed to stir at room temperature. After completion or
24 hours (whichever came first), the reaction was quenched
with saturated ammonium chloride, separated with diethyl
ether, dried with magnesium sulphate and the solvent
removed in vacuo. A 1H NMR was performed at this point to
determine the conversion. Purification by column chromato-
graphy (SiO2, 5% EtOAc/hexane) gave the product (S)-10 as a
colourless oil for which the 1H/13C NMR spectra matched pre-
viously reported data.33 The enantiomeric excess was deter-
mined by HPLC analysis using a CHIRALCEL OD-H column;
eluent = 98 : 2 (hexane : IPA); flow rate = 0.5 mL min−1; con-
centration = 0.0015 g mL−1, injection volume = 5 µl, wave-
length = 254 nm. (S)-Enantiomer RT = 20.5 min, (R)-enantio-
mer RT = 18.9 min.
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